TAYLER MCARTHUR: Open Payments
NPI 1467921601 · ABINGDON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 45 payments from 11 companies in 2025. Trend: 2023 $456 · 2024 $574 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $165 |
| Janssen Pharmaceuticals, Inc | 7 | $159 |
| Braeburn Inc. | 6 | $110 |
| Alkermes, Inc. | 5 | $91 |
| Teva Pharmaceuticals USA, Inc. | 5 | $87 |
| Neurocrine BioSciences, Inc. | 4 | $81 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Indivior Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $20 |
Products named: COBENFY, INVEGA SUSTENNA, BRIXADI, INGREZZA, ARISTADA, AUSTEDO XR, CAPLYTA, ABILIFY ASIMTUFII.
Industry payments across VA — which companies pay providers there.
